Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.400
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $129.43 million as of April 29, 2026. Its market cap has decreased by -22.59% in one year.
Market Cap
129.43M
Enterprise Value
115.68M
1-Year Change
-22.59%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $129.43M, an increase of 3.36%. That is a compound annual growth rate of 0.25%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunic | 140.25M |
| Connect Biopharma Holdings | 135.65M |
| TuHURA Biosciences | 135.42M |
| Kazia Therapeutics | 135.41M |
| Alpha Cognition | 135.00M |
| Equillium | 129.61M |
| Kalaris Therapeutics | 129.20M |
| Edesa Biotech | 126.71M |